Ghosh R, Narasanna A, Wang SE, Liu S., Balko JM, Gonzalez AM, Mills GB, Penuel E, Winslow J, Sperinde J, Leitzel K, Kostler WJ, Lipton A, Bates M, and Arteaga C. Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers. Cancer Res. 2011 Mar 1;71(5):1871-82. - Stand Up To Cancer

Blog

Posted September 17, 2019

Ghosh R, Narasanna A, Wang SE, Liu S., Balko JM, Gonzalez AM, Mills GB, Penuel E, Winslow J, Sperinde J, Leitzel K, Kostler WJ, Lipton A, Bates M, and Arteaga C. Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers. Cancer Res. 2011 Mar 1;71(5):1871-82.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.